tisagenlecleucel
/ˌtɪsəd͡ʒɛnləˈkluːsəl/
tisagenlecleucel noun: an anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies.
Noun
tisagenlecleucel (uncountable)
- An anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies.
Origin of tisagenlecleucel
From tisa- (unique name) + -gen- (“transfer of genetic material (transduced)”) + -lec- (“selection and enrichment manipulation”) + -leu- (“leukocytes”) + -cel (“cellular therapy”).
Questions about tisagenlecleucel
- What does tisagenlecleucel mean?
- Tisagenlecleucel means an anti-CD19 CAR-T cell therapy used in the treatment of haematological malignancies.
- What part of speech is tisagenlecleucel?
- Tisagenlecleucel is a noun.
- How do you pronounce tisagenlecleucel?
- Tisagenlecleucel is pronounced /ˌtɪsəd͡ʒɛnləˈkluːsəl/.
Words near tisagenlecleucel in the dictionary
Source and license
Adapted from Wiktionary: tisagenlecleucel (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “tisagenlecleucel.” Word.ws, https://word.ws/tisagenlecleucel. Based on Wiktionary, CC BY-SA 4.0.
